In a study spanning January 2022 to January 2023, researchers explored the safety and viability of a pioneering stent-assisted ileal bypass for individuals undergoing sphincter-preserving surgery for rectal cancer. With 11 successful cases, the innovative approach, involving a biofragmentable ileal stent and diversion tube, proved safe and feasible. Results indicated potential benefits, including the avoidance of protective stomas and reduced need for secondary surgeries, offering a promising alternative for rectal cancer patients.
Journal Article by Wen ZL, Bai L and Zhou X in ANZ J Surg
© 2023 Royal Australasian College of Surgeons.